Evidence map›Paper›PMID 42325669›Full record

ReviewFrontiers in cardiovascular medicine2026

Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies.

Clark Zheng, Kelsey Muir, Himanshu Kaushik, Keertana Yalamanchili, Keyana Zahiri, Adam Yeo, Justin Kim, Frank W Sellke

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clark ZhengDepartment of Surgery, Division of Cardiothoracic Surgery, Warren Alpert Medical School of Brown University, Providence, RI, United States.
Kelsey MuirDepartment of Surgery, Division of Cardiothoracic Surgery, Warren Alpert Medical School of Brown University, Providence, RI, United States.
Himanshu KaushikCardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI, United States.
Keertana YalamanchiliCardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI, United States.
Keyana ZahiriCardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI, United States.
Adam YeoCardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI, United States.
Justin KimCardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI, United States.
Frank W SellkeDepartment of Surgery, Division of Cardiothoracic Surgery, Warren Alpert Medical School of Brown University, Providence, RI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiopulmonary bypass (CPB) is a crucial component of cardiac surgery, yet postoperative organ dysfunction remains common despite apparently adequate systemic hemodynamics. This mismatch underscores the importance of the microcirculation, where oxygen delivery and extraction ultimately occur. Increasing evidence suggests that CPB disrupts capillary perfusion through endothelial dysfunction, glycocalyx shedding, inflammation, oxidative stress, hemodilution, functional shunting, and microthromboemboli, thereby causing tissue hypoxia despite normal macro-hemodynamic stability. This review summarizes the physiology of microcirculation and examines the mechanisms by which CPB impairs microvascular function. We also review current tools for microcirculatory assessment, including orthogonal polarization spectral, sidestream dark field, and incident dark field imaging, near-infrared spectroscopy, and circulating biomarkers of endothelial and glycocalyx injury. Although these approaches have improved mechanistic insight, their clinical use remains limited by technical challenges and the lack of standardized endpoints. We further evaluate cardioprotective strategies aimed at preserving microcirculatory function during CPB. These include perfusion and mechanical approaches, ischemic preconditioning, glycocalyx-preserving therapies, and various pharmacologic interventions such as volatile anesthetics, nitric oxide, statins, antioxidants, and antithrombotic agents. Across these domains, preclinical studies often support biologic plausibility, whereas clinical evidence remains heterogeneous and inconclusive and frequently relies on indirect evidence of organ dysfunction rather than direct measures of microvascular perfusion. Important gaps remain in translating findings from experimental models to patients, and greater integration of bedside imaging and biomarkers with biophysiological principles may help establish microcirculation as both a mechanistic endpoint and a therapeutic target in cardiac surgery.

Indexed as

cardiopulmonary bypasshemodilutionmicrocirculationmicrocirculatory dysfunctionmicrovessel

Identifiers

PMID42325669
PMCPMC13278890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.